These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26234500)

  • 1. Analysis of kinetic curve and model-based perfusion parameters on dynamic contrast enhanced MRI in breast cancer patients: Correlations with dominant stroma type.
    Yim H; Kang DK; Jung YS; Jeon GS; Kim TH
    Magn Reson Imaging; 2016 Jan; 34(1):60-5. PubMed ID: 26234500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
    Koo HR; Cho N; Song IC; Kim H; Chang JM; Yi A; Yun BL; Moon WK
    J Magn Reson Imaging; 2012 Jul; 36(1):145-51. PubMed ID: 22392859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model.
    Davenport MS; Heye T; Dale BM; Horvath JJ; Breault SR; Feuerlein S; Bashir MR; Boll DT; Merkle EM
    J Magn Reson Imaging; 2013 Aug; 38(2):329-35. PubMed ID: 23239041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.
    Jena A; Mehta SB; Taneja S
    J Magn Reson Imaging; 2013 Sep; 38(3):573-9. PubMed ID: 23349046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis.
    Nilsen LB; Fangberget A; Geier OM; Engebraaten O; Borgen E; Olsen DR; Seierstad T
    J Magn Reson Imaging; 2014 Dec; 40(6):1382-91. PubMed ID: 24470360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent diffusion coefficient in estrogen receptor-positive invasive ductal breast carcinoma: correlations with tumor-stroma ratio.
    Ko ES; Han BK; Kim RB; Cho EY; Ahn S; Nam SJ; Ko EY; Shin JH; Hahn SY
    Radiology; 2014 Apr; 271(1):30-7. PubMed ID: 24475830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.
    Liu K; Xie P; Peng W; Zhou Z
    J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of quantitative perfusion parameters on dynamic contrast-enhanced MRI in mammographically occult breast cancer.
    Ryu JK; Rhee SJ; Song JY; Cho SH; Jahng GH
    J Appl Clin Med Phys; 2016 Sep; 17(5):377-390. PubMed ID: 27685105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
    Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
    J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
    Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
    Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of apparent diffusion coefficient and quantitative kinetic parameters for predicting additional malignancy in patients with newly diagnosed breast cancer.
    Yoo H; Shin HJ; Baek S; Cha JH; Kim H; Chae EY; Kim HH
    Magn Reson Imaging; 2014 Sep; 32(7):867-74. PubMed ID: 24907855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravoxel incoherent motion diffusion-weighted MRI in patients with breast cancer: Correlation with tumor stroma characteristics.
    Li Y; Wang Z; Chen F; Qin X; Li C; Zhao Y; Yan C; Wu Y; Hao P; Xu Y
    Eur J Radiol; 2019 Nov; 120():108686. PubMed ID: 31586850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Microcirculation of Normal Extraocular Muscles Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Guo Y; Huo L; Wang P; Huang L; Chai C; Sun F; Xia S; Shen W
    J Comput Assist Tomogr; 2016; 40(3):419-23. PubMed ID: 26953768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
    Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
    Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there any correlation between model-based perfusion parameters and model-free parameters of time-signal intensity curve on dynamic contrast enhanced MRI in breast cancer patients?
    Yi B; Kang DK; Yoon D; Jung YS; Kim KS; Yim H; Kim TH
    Eur Radiol; 2014 May; 24(5):1089-96. PubMed ID: 24553785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of two-compartment-exchange-model analysis for dynamic contrast-enhanced mri incorporating bolus arrival time.
    Nadav G; Liberman G; Artzi M; Kiryati N; Bashat DB
    J Magn Reson Imaging; 2017 Jan; 45(1):237-249. PubMed ID: 27383624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
    Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
    Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes.
    Blaschke E; Abe H
    J Magn Reson Imaging; 2015 Oct; 42(4):920-4. PubMed ID: 25758675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.